Similar results were observed in prostate cancer and Wilms’ tumor: halofuginone, but not the respective chemotherapies, inhibited synthesis of collagen type I, αSMA, SM22α, and Cygb/STAP, all of which are characteristic of activated myofibroblasts. The gene discussed is ACTA1; the disease is prostate carcinoma.